## Abstract Human tumor cells expressing ganglioside GD2 were lysed by various effector populations targeted with an antiโCD3โantiโGD2 biโspecific antibody (BAb CD3 x GD2). This antibodyheteroconjugate was prepared by chemically crossโlinking the OKTโ3 monoclonal antibody (MAb) reactive with CD3 an
Potentiation of interleukin-2 production and its binding by monoclonal antibodies to the gangliosides GD3 and GD2
โ Scribed by Stephen Schibeci; Peter Hersey; David Cheresh
- Publisher
- Springer-Verlag
- Year
- 1989
- Tongue
- English
- Weight
- 986 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Among the developmentally regulated antigens expressed on the surface of bipotential glial precursors isolated from neonatal rat brain are the gangliosides recognized by the monoclonal antibody A2B5. Immunostaining of thin layer chromatograms showed that oligodendrocyte-type 2 astrocyte (O2A) progen
A mouse anti-rat interleukin 2 (IL 2) receptor (IL 2R) monoclonal antibody (mAb), ART-65, has been developed. As shown by fluorescence-activated cell sorter analysis and immunoprecipitation studies, ART-65 recognizes in a species-specific manner the same molecule as does ART-18, a mAb which has been